Yahoo! Finance Search - Finance Home - Yahoo! - Help

Monday, November 24 2014 7:29am ET - U.S. Markets open in 2 hours and 1 minute.
Industry Center - Drug Manufacturers - Major
Industry Center > Drug Manufacturers - Major > News
More On This Industry
· Summary
·Leaders & Laggards
· Company Index
·Industry Browser
Related Industries
· Biotechnology
· Diagnostic Substances
· Drug Delivery
· Drug Manufacturers - Other
· Drug Related Products
· Drugs - Generic
· REIT - Retail
Top Industries
·Aerospace/Defense - Major Diversified
·Auto Manufacturers - Major
·Business Software & Services
·Chemicals - Major Diversified
·Communication Equipment
·Diversified Computer Systems
·Diversified Investments
·Drug Manufacturers - Major
·Electric Utilities
·Food - Major Diversified
·Industrial Metals & Minerals
·Major Airlines
·Major Integrated Oil & Gas
·Money Center Banks
·Property & Casualty Insurance
·Semiconductor - Broad Line
·Telecom Services - Domestic
Complete Industry List...
Drug Manufacturers - Major News
Latest News
Monday, Nov 24, 2014
·Sanofi Shakes Off Patent Losses - 29 minutes ago
·GW Pharmaceuticals to Report Q4, Year-End 2014 Financial Results and Host Conference Call on 2 December, 2014
GlobeNewswire - Mon 2:00 am ET
Sunday, Nov 23, 2014
·Anthera Pharmaceuticals to Present at Annual Piper Jaffray Healthcare Conference
PR Newswire - Sun 9:30 pm ET
Saturday, Nov 22, 2014
·Motley Fool: Pundits pandering your wealth away
- Sat Nov 22
Friday, Nov 21, 2014
·INVESTOR ALERT: Faruqi & Faruqi, LLP Encourages Investors Who Suffered Losses in Excess of $100,000 Investing in Retrophin, Inc. (RTRX) to Contact the Firm
GlobeNewswire - Fri Nov 21
·EQUITY ALERT: Rosen Law Firm Reminds Pacira Pharmaceuticals, Inc. Investors of Important December 2, 2014 Deadline in Class Action -- PCRX
GlobeNewswire - Fri Nov 21
·Tetraphase Said to Explore Sale After Takeover Interest
at Bloomberg - Fri Nov 21
·Final Glance: Pharmaceuticals companies
AP - Fri Nov 21
·MannKind's Afrezza Remains in Sanofi's Plans, RBC Says
at - Fri Nov 21
·You Should Hold Merck According to Dividends Generation
- Fri Nov 21
·Encouraging Results For Two New Drugs That Fight A Common And Dangerous Side Effect
at - Fri Nov 21
·ZS Pharma Announces Publication of Results From Phase 3 Study of ZS-9 in Patients With Hyperkalemia in the New England Journal of Medicine
GlobeNewswire - Fri Nov 21
·AstraZeneca Announces Plans to Expand its Frederick, Maryland Biologics Manufacturing Center
Business Wire - Fri Nov 21
·Early Glance: Pharmaceuticals companies
AP - Fri Nov 21
·Today's Momo Momentum Stock Is Merck (MRK)
at - Fri Nov 21
·Europe gives green light to AbbVie hepatitis C drugs, others
Reuters - Fri Nov 21
·Intra-Cellular Therapies Announces Additional Results From Phase I/II Clinical Trial for ITI-007 in Healthy Geriatric Subjects and Patients With Dementia
GlobeNewswire - Fri Nov 21
·Do The IMPROVE-IT Results Offer Promise For Anacetrapib, Another Merck Heart Drug?
at - Fri Nov 21
·CHMP Grants Positive Opinions of AbbVie's VIEKIRAX™ (ombitasvir/paritaprevir/ritonavir) + EXVIERA™ (dasabuvir) for the Treatment of Chronic Hepatitis C in Europe
PR Newswire - Fri Nov 21
·Europe gives green light to AbbVie hepatitis C medicine, others
Reuters - Fri Nov 21
More Latest News...
Sponsor Results
Professional Statistician
All areas of research. Free initial consultation. 877-461-7226
ChainStoreGuide Newsroom
Get Industry News & Insights By Our Experienced Editorial Staff.
Looking for a Job?
Huge opportunity to join an amazing team of compound pain cream reps.
(What's This?)

RSS Feeds

Add headlines to your
personalized My Yahoo Page
( About My Yahoo and RSS )

Drug Manufacturers - Major Headlines
More Finance RSS Feeds

Copyright © 2014 Yahoo! Inc. All rights reserved. Privacy Policy - Terms of Service
Industry information © 2014 Morningstar, Inc. All Rights Reserved. Company information © 2014 Capital IQ All Rights Reserved. Quotes and other information supplied by independent providers identified on the Yahoo Finance partner page. S&P 500 index provided by Comstock. All rights reserved. Top-Ranked Analyst information © 1999-2014, StarMine Corp. All rights reserved. Data and information is provided for informational purposes only, and is not intended for trading purposes. Neither Yahoo nor any of its data or content providers (such as Capital IQ, Morningstar, CSI and exchanges) shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. By accessing the Yahoo site, a user agrees not to redistribute the information found therein.

Questions or Comments?